UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000062539
Receipt number R000069425
Scientific Title Immediate effects of AI-based real-time feedback of lumbar moment on biomechanical low back load during patient transfer: a randomized controlled trial
Date of disclosure of the study information 2026/08/10
Last modified on 2026/08/10 14:49:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of AI-based real-time feedback on low back load during patient transfer assistance: a randomized controlled trial

Acronym

AI-Transfer Feedback Trial

Scientific Title

Immediate effects of AI-based real-time feedback of lumbar moment on biomechanical low back load during patient transfer: a randomized controlled trial

Scientific Title:Acronym

AI-Transfer RCT

Region

Japan


Condition

Condition

Low back load during patient transfer assistance in healthcare workers (healthy volunteers)

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the immediate effects of AI-based real-time feedback of lumbar moment waveforms, derived from markerless motion analysis (VP-Ergono), in addition to standard transfer instruction and review of participants' own video, on biomechanical low back load (peak lumbar moment and cumulative lumbar load) during patient transfer among healthcare workers who routinely perform transfer assistance. The association between changes in mechanical load and acute subjective burden (pre-to-post changes in pain and fatigue) is also examined. This is a single-session, immediate intervention; effects on chronic low back pain are not evaluated. The direction of change in lumbar load is not prespecified.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Co-primary outcomes (both derived from markerless motion analysis of video; between-group comparison of pre-to-post change): (1) peak lumbar moment (Nm) during patient transfer, and (2) cumulative lumbar load (Nm x s, natural-log transformed). Multiplicity is adjusted by the Bonferroni method (two-sided alpha = 0.025 for each). The direction of change is not prespecified; two-sided tests are used.

Key secondary outcomes

Secondary outcomes: (1) pain VAS/NRS (change from immediately before to immediately after the transfer task), (2) fatigue VAS/NRS (same), (3) median %RVE of the right multifidus (surface EMG, primary interest), (4) median %RVE of the left multifidus (control). Exploratory outcomes: integrated EMG (limited to recordings with adequate electrode contact), rate of change in lumbar moment, right-left asymmetry, and group-by-professional-category and group-by-history-of-low-back-pain interactions (hypothesis-generating).


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Device,equipment Behavior,custom

Interventions/Control_1

In addition to standard transfer instruction, participants review video of their own transfer performance and receive real-time feedback of lumbar moment waveforms derived from markerless motion analysis (VP-Ergono) (single session).

Interventions/Control_2

In addition to standard transfer instruction, participants review video of their own transfer performance without presentation of lumbar moment waveforms (single session). Both groups receive standard instruction and video review, so the between-group difference is limited to the presence or absence of AI feedback (waveform presentation).

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Physical therapists, occupational therapists, speech-language-hearing therapists, nurses, and care workers employed by the medical corporation who provide written informed consent.

Key exclusion criteria

Individuals with severe acute low back pain or neurological symptoms that make it difficult to perform the measurement task; and individuals whom the principal investigator judges to be unsuitable for participation.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Daichi
Middle name
Last name Yoshida

Organization

Fukuoka Sakurajuji Medical Corporation Hanabatake Hospital / Fukuoka Sakurajuji Medical Corporation (Sakurajuji Advanced Rehabilitation Center SACRA)

Division name

Rehabilitation Department

Zip code

830-0038

Address

914 Nishimachi, Kurume City, Fukuoka Prefecture

TEL

0942-32-4565

Email

mugonjikkou@yahoo.co.jp


Public contact

Name of contact person

1st name Daichi
Middle name
Last name Yoshida

Organization

Fukuoka Sakurajuji Medical Corporation Hanabatake Hospital

Division name

Rehabilitation Department

Zip code

830-0038

Address

914 Nishimachi, Kurume City, Fukuoka Prefecture

TEL

09092057660

Homepage URL


Email

mugonjikkou@yahoo.co.jp


Sponsor or person

Institute

Fukuoka Sakurajuji Medical Corporation (Sakurajuji Advanced Rehabilitation Center SACRA)

Institute

Department

Personal name

Daichi Yoshida


Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Faculty of Rehabilitation, Nishi Kyushu University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Sakurajyuji Fukuoka Hospital

Address

5-11 Watanabe-dori 3-chome, Chuo Ward, Fukuoka City

Tel

092-791-1100

Email

mugonjikkou@yahoo.co.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

25K13431

Org. issuing International ID_1

Japan Society for the Promotion of Science (JSPS)

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人福岡桜十字 花畑病院(福岡県)


Other administrative information

Date of disclosure of the study information

2026 Year 08 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2026 Year 02 Month 17 Day

Date of IRB

2026 Year 02 Month 17 Day

Anticipated trial start date

2026 Year 02 Month 18 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This trial is registered retrospectively (the first participant was measured on February 18, 2026; UMIN registration occurred thereafter). Thirteen participants had been allocated before UMIN registration; all are included in the trial to preserve the randomness of the allocation sequence. Data from the internal pilot are used only for blinded re-estimation of nuisance parameters (variance and correlation), with no between-group comparison. If the pre-registered allocations are unbalanced, subsequent allocations will be adjusted so that each arm reaches 30 participants (total unchanged). The professional composition is 40 rehabilitation professionals to 20 nursing and care workers (approximately 2:1). Speech-language-hearing therapists are covered by the ethics approval but are excluded from the primary analysis by prespecification because of their low frequency of transfer assistance. Outcome assessment and analysis are performed under blinding using file names that contain no allocation information. The primary analysis is ANCOVA with baseline value, professional category, age, years of experience, BMI, and history of low back pain as covariates.


Management information

Registered date

2026 Year 08 Month 10 Day

Last modified on

2026 Year 08 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069425